Astrazeneca (AZN) Ending Cash Balance (2009 - 2026)
Astrazeneca's Ending Cash Balance came in at $7.94 billion for Q3 2026, down 2.5% from $8.14 billion a year earlier but up 62.5% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Astrazeneca's Ending Cash Balance was $5.7 billion, up 5.0% from FY2024.
- Ending Cash Balance carries a five-year compound annual growth rate of -5.5% (FY2020 to FY2025).
- Going back by year, Ending Cash Balance was $5.43 billion in FY2024 (-3.7%), $5.64 billion in FY2023 (-5.8%), $5.98 billion in FY2022 (-0.9%) and $6.04 billion in FY2021 (-20.0%).
- The five-year range for quarterly Ending Cash Balance is $4.8 billion (Q3 2024) to $8.14 billion (Q3 2025).
- Year-over-year, Ending Cash Balance increased in four of the last eight quarters, with growth averaging 6.4%.
- The fastest year-over-year change in Ending Cash Balance over five years came in Q3 2025 (growth of 69.8%), and the weakest in Q2 2022 (a decline of 68.3%).
- Business Quant data shows AZN's Ending Cash Balance at $4.88 billion (Q2 2026), $7.56 billion (Q1 2026) and $5.7 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.99 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.94 Bn |
| Jun 30, 2026 | 4.88 Bn |
| Mar 31, 2026 | 7.56 Bn |
| Dec 31, 2025 | 5.70 Bn |
| Sep 30, 2025 | 8.14 Bn |
| Jun 30, 2025 | 7.03 Bn |
| Mar 31, 2025 | 5.23 Bn |
| Dec 31, 2024 | 5.43 Bn |
| Sep 30, 2024 | 4.80 Bn |
| Jun 30, 2024 | 6.92 Bn |
| Mar 31, 2024 | 7.84 Bn |
| Dec 31, 2023 | 5.64 Bn |
| Jun 30, 2023 | 5.66 Bn |
| Mar 31, 2023 | 6.23 Bn |
| Dec 31, 2022 | 5.98 Bn |
| Jun 30, 2022 | 4.82 Bn |
| Mar 31, 2022 | 5.76 Bn |
| Dec 31, 2021 | 6.04 Bn |
| Sep 30, 2021 | 7.07 Bn |
| Jun 30, 2021 | 15.20 Bn |
API Access
Astrazeneca Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();